Sinovac Biotech (NASDAQ:SVA) reported quarterly earnings of $0.06 per share. This is a 94.92 percent decrease over earnings of $1.18 per share from the same period last year. The company reported $130.270 million in sales this quarter. This is a 1.21 percent increase over sales of $128.711 million the same period last year.